MTOR and neoplasm: Together, these findings provide strong evidence for the tumor-intrinsic molecular alterations induced by the RAC1A159V mutation that promote tumor cell glycolysis, suppress chemokine production, and reduce cell surface IFNGR1 via glycosphingolipid mediated mTOR activation (Fig. 5M).